Genetic Screening No Use in Predicting Heart Attack Risk

Sunday, March 15, 2009 by: David Gutierrez, staff writer
Tags: genetic screening, health news, Natural News

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
GMO crops totally banned in Russia... powerful nation blocks Monsanto's agricultural imperialism and mass poisoning of the population
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Pepsi drops aspartame from diet soda as consumers reject toxic sweetener
Bride of Frankenfood: Hillary Clinton pushes GMO agenda... hires Monsanto lobbyist... takes huge dollars from Monsanto
STATINS RED ALERT: Widely prescribed drugs act as cellular poisons that accelerate aging... deactivate DNA repair... promote diabetes, muscle fatigue and memory loss
Wild eyes and bowl cuts: Why do mass shooters always share the same hair styles and crazed zombie stares?
Mind control through emotional domination: How we're all being manipulated by the "crisis of the NOW"
(NaturalNews) Genetic screening for the trait most strongly linked to early heart attacks does not, in fact, improve the ability to predict the risk of heart attack or other forms of cardiovascular disease, a new study has concluded.

"Once you already know the traditional risk factors, the additional information about the genetic variation doesn't help any," lead researcher Nina Paynter said. "It doesn't improve your ability to predict."

The trait in question is a type of genetic variation known as a single nucleotide polymorphism (SNP), occurring on chromosome 9. The variation, 9p21, is currently the strongest known genetic predictor of early heart attack. Although scientists are still unsure exactly what the function is of the gene that 9p21 is located in, carrying one copy of the genetic trait is believed to be associated with a 20 percent increased risk of early heart attack. The trait has also been associated with a significantly increased risk of other forms of cardiovascular disease, such as stroke, abdominal aortic aneurysm and intracranial aneurysm.

With genetic screening increasingly entering the public consciousness, some businesses have started offering commercial 9p21 screenings, purporting to help people estimate their heart attack risk. In the current study, published in the journal Annals of Internal Medicine, researchers from Brigham and Women's Hospital and Boston sought to determine if genetic screening of individuals could actually provide any predictive benefit.

"Gene patterns are associated with an increased risk of heart disease, and the higher risk patterns are common," Paynter said. "However, it was not known if knowledge of a person's pattern, when added to knowledge of traditional risk factors including family history of heart disease, would improve the ability to predict levels of future heart disease risk for that person and possibly help with treatment decisions."

In the end, knowing 9p21 status provided no benefit over knowledge of risk factors such as family history, blood pressure, cholesterol, diabetes status, smoking status and even levels of the arterial inflammation marker C-reactive protein.

The researchers assessed the 9p21 status of 22,129 white female health care professionals in the United States, along with several well-known cardiovascular risk factors. They then followed the participants for 10.2 years. All participants were free of major chronic disease at the beginning of the study.

The presence of 9p21 did, as in prior studies, correlate with a 25 to 30 percent higher risk of cardiovascular disease. This predictive effect was dwarfed, however, by those of other risk factors. When 9p21 status was incorporated into two common cardiovascular risk assessments, it only marginally improved accuracy in one test, while actually worsening it in the other.

"It seems unlikely that screening for SNPs in this region will be clinically useful in daily practice," the researchers concluded.

While the current study looked at the population-level value of 9p21 testing in predicting cardiovascular disease, Paynter noted that the tests are not useful for individuals, either.

"On a personal level, having the 9p21 variation tells you that your own personal risk is increased, but in middle age, women are at a fairly low risk anyway, and that 20 percent increased risk doesn't bump you up to medium or high risk for cardiovascular disease," she said. "For most people, it just puts you at a slightly higher, very low risk."

According to many scientists, the study calls into question the utility of genetic screening for chronic disease risk, in general.

"It's an important study that should give us pause that information about whether our DNA will trump what we know from established risk factors," said Harlan M. Krumholz of Yale University. "The genetic work is important in efforts to find targets for future therapies, but addressing modifiable risk factors is where we need to direct our attention."

Sources for this story include: www.reuters.com; www.washingtonpost.com; www.modernmedicine.com; www.theheart.org.

Follow real-time breaking news headlines on
Genetic screening at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.